![PR PR](https://pulmonaryfibrosistrust.org/wp-content/uploads/bb-plugin/cache/PR-200x200-circle-aff835e49a0fcbe7b776ecb243a3c6a6-sfuio5y8c1lq.jpg)
Pulmonary rehabilitation
An exercise programme designed to reduce breathlessness by teaching breathing techniques and improve general fitness level.
![medication medication](https://pulmonaryfibrosistrust.org/wp-content/uploads/bb-plugin/cache/medication-200x200-circle-947bd341a024177e5486251543da7c4a-15vk4bqxjscf.jpg)
Medication
There are two drugs which slow down disease progression by reducing lung scarring: Nintedanib and Pirfenidone.
This medication is only currently available to patients diagnosed with IPF.
![Oxygen Oxygen](https://pulmonaryfibrosistrust.org/wp-content/uploads/bb-plugin/cache/Oxygen-200x200-circle-a1d9f085e8168367c1315f4ab464678c-zavk8yi79h26.jpg)
Oxygen therapy
Supplemental oxygen is used to treat low oxygen level (hypoxaemia) in the blood caused by scarring via a nasal cannula or a face mask.
Ambulatory oxygen therapy is given/taken additionally during exercise and everyday living activities.
As the disease progresses (severe hypoxaemia) you may require constant oxygen supplementation.
![Stomach Stomach](https://pulmonaryfibrosistrust.org/wp-content/uploads/bb-plugin/cache/Stomach-200x200-circle-65c9baa27bea939486d47403a49a641b-8ulgdje342zp.jpg)
Stomach acid reduction
Omeprazole and lansoprazole are medications which reduce the production of stomach acid and antacids neutralise stomach acid.
![CBT CBT](https://pulmonaryfibrosistrust.org/wp-content/uploads/bb-plugin/cache/CBT-200x200-circle-7cdc4a346cfb5719bf4ee304a0b75fa8-cjzs2rbpxh9e.jpg)
Cognitive behavioural therapy/anti-depressants
To manage possible anxiety/depression caused by the PF diagnosis.
![Transplant Transplant](https://pulmonaryfibrosistrust.org/wp-content/uploads/bb-plugin/cache/Transplant-200x200-circle-e579c969ba2370d0717130cc332707d2-fc65osgva40q.jpg)
Lung transplantation
Transplant of one or both lungs from a donor.
Only 5% of PF patients qualify for the procedure for a number of reasons including their age and other health problems.
Content acknowledgements: © 2022 by the University of Hull and Authors. A Patient's Guide to Pulmonary Fibrosis Second Edition